Last reviewed · How we verify

Actidose Aqua — Competitive Intelligence Brief

Actidose Aqua (Actidose Aqua) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Adsorbent antidote. Area: Toxicology / Poison Control.

marketed Adsorbent antidote Toxicology / Poison Control Small molecule Live · refreshed every 30 min

Target snapshot

Actidose Aqua (Actidose Aqua) — National Institute of Allergy and Infectious Diseases (NIAID). Actidose Aqua is an aqueous suspension of activated charcoal that binds toxins and drugs in the gastrointestinal tract to prevent their absorption.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Actidose Aqua TARGET Actidose Aqua National Institute of Allergy and Infectious Diseases (NIAID) marketed Adsorbent antidote
Activated Charcoal Activated Charcoal State University of New York - Upstate Medical University marketed Adsorbent antidote

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Adsorbent antidote class)

  1. National Institute of Allergy and Infectious Diseases (NIAID) · 1 drug in this class
  2. State University of New York - Upstate Medical University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Actidose Aqua — Competitive Intelligence Brief. https://druglandscape.com/ci/actidose-aqua. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: